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53-60 PROBIOTICS TO YOUNG CHILDREN WITH ATOPIC DERMATITIS: A 
 RANDOMIZED PLACEBO-CONTROLLED TRIAL 
 R Gøbel, N Larsen, C Mølgaard, M Jakobsen and KF Michaelsen 
 
ABSTRACT: Impairment of the intestinal mucosal barrier is involved in the pathogenesis of 
atopic dermatitis (AD), and studies suggest that probiotics stabilize the intestinal barrier 
function and decrease gastrointestinal symptoms in children with AD. The purpose of this 
study was to evaluate the clinical and immunological changes of AD after consumption of the 
probiotic strains Lactobacillus acidophilus NCFM and Bifidobacterium animalis subsp. lactis 
Bi-07. Double-blind, randomized placebo-controlled intervention study. Fifty children (mean 
age 18 months) with AD received NCFM (1010 CFU/day), Bi-07 (1010 CFU/day) or placebo for 
8 weeks. The immunological activity and clinical effect was evaluated by IgE, ECP, IL-10, 
IFN-ϒ , IL-31, faecal calprotectin and SCORAD index. There were no overall beneficial 
effects of the probiotic strains on the degree of AD measured by SCORAD index. However, a 
post hoc analysis showed a significant reduction in severity of AD in the Bi-07 group and 
together with the decreasing levels of IFN-γ and IL-10 possible beneficial effects of this 
probiotic strain could be of interest. There was no effect on inflammatory markers or faecal 
calprotectin. The significant correlation between ECP and SCORAD index suggest the use of 
ECP as a measure of the degree of AD in children.  
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61-68 EFFECTS OF A NOVEL GALACTOOLIGOSACCHARIDE ON THE FAECAL 
 MICROBIOTA OF HEALTHY AND INFLAMMATORY BOWEL DISEASE 
 CATS DURING A  RANDOMIZED, DOUBLE-BLIND, CROSS-OVER 
 FEEDING STUDY 
 Leticia Abecia, Lesley Hoyles, Christina Khoo, Nolan Frantz and Anne L. McCartney 
 
ABSTRACT: Inflammatory bowel disease (IBD) is a common gastrointestinal disorder of cats 
with no known aetiological agent. Previous work has suggested that the faecal microbiota of 
IBD cats is significantly different from that of healthy cats, including significantly lower 
bifidobacteria, bacteroides and total counts in IBD cats and significantly lower levels of 
sulfate-reducing bacteria in healthy cats. Prebiotics, including galactooligosaccharides (GOS), 
have been shown to elicit a bifidogenic effect in humans and other animals. The purpose of 
the current study was to examine the impact of a novel GOS supplementation on the faecal 
microbiota of healthy and IBD cats during a randomized, double-blind, cross-over feeding 
study. Eight oligonucleotide probes targeting specific bacterial populations and DAPI stain 
(total bacteria) were used to monitor the feline faecal microbiota. Overall, inter-animal 
variation was high; while a trend of increased bifidobacterial levels was seen with GOS 
supplementation it was not statistically significant in either healthy or IBD cats. No significant 
differences were observed in the faecal microbiota of IBD cats and healthy cats fed the same 
diet. Members of the family Coriobacteriaceae (Atopobium cluster) were found to be the most 
abundant bacteria in the feline microbiota. 
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69-74 A DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER-DESIGNED 
 PROBIOTIC  FEEDING  STUDY IN CHILDREN DIAGNOSED WITH AUTISTIC 
 SPECTRUM DISORDERS 
 Helena M. R. T. Parracho, Glenn R. Gibson, Fiona Knott, Douwina Bosscher, Michiel 
 Kleerebezem and Anne L. McCartney 
 
ABSTRACT: There is growing interest in the role of gastrointestinal (GI) pathology and 
clinical expression of autism. Recent studies have demonstrated differences in the faecal 
clostridial populations harboured by autistic and non-autistic children. The potential of 
Lactobacillus plantarum WCSF1 (a probiotic) to modulate the gut microbiota of autistic 
subjects was investigated during a double-blind, placebo-controlled, crossover-designed 
feeding study. The faecal microbiota, gut function and behaviour scores of subjects were 
examined throughout the 12-week study. Lactobacillus plantarum WCFS1 feeding 
significantly increased Lab158 counts (lactobacilli and enterococci group) and significantly 
reduced Erec482 counts (Clostridium cluster XIVa) compared to placebo. Probiotic feeding 
also resulted in significant differences in the stool consistency compared to placebo and 
behaviour scores (total score and scores for some subscales) compared to baseline. The major 
finding of this work was the importance of study protocol in relation to the specific 
considerations of this subject population, with an extremely high dropout rate seen 
(predominantly during the baseline period). Furthermore, the relatively high inter-individual 
variability observed suggests that subsequent studies should use defined subgroups of autistic 
spectrum disorders, such as regressive or late-onset autism. In summary, the current study has 
highlighted the potential benefit of L. plantarum WCFS1 probiotic feeding in autistic 
individuals. 
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75-84 A DOUBLE-BLIND, PLACEBO CONTROLLED HUMAN STUDY 
 INVESTIGATING THE EFFECTS OF COFFEE DERIVED MANNO-
 OLIGOSACCHARIDES ON THE FAECAL MICROBIOTA OF A HEALTHY 
 ADULT POPULATION 
 GE Walton, RA Rastall, MC Martini, CE Williams, RL Jeffries and GR Gibson 
 
ABSTRACT: The aims of this study were to assess the impact of coffee derived 
mannooligosaccharides on the faecal microbiota of a healthy UK based population. Methods 
and Results: A double-blind, placebo-controlled, crossover human intervention study was 
conducted. Volunteers were assigned, 3g MOS, 5g MOS and placebo coffee preparations, to 
consume daily over a 3 wks, followed by a 2 wk washout period. Faecal samples were 
collected, and microbial population characterised using fluorescence in situ hybridization. 
Short-chain and branched-chain fatty acid profiles were obtained by gas chromatography. All 
treatments led to significant lactobacilli increases (placebo, p < 0.001; 3g, p = 0.04; 5g, p= 
0.04). The 3g treatment led to a significant bifidobacteria increase (p=0.001). Significantly less 
iso-valerate was found in faeces following 3g MOS daily (p=0.05). Conclusions: The 3g dose 
of MOS led to a potentially beneficial shift in the faecal microbiota. MOS was therefore 
confirmed to be a prebiotic at 3g dose. Significance and Impact of Study: This study provides 
confirmation of a new novel prebiotic, that can be considered for incorporation into a wider 
variety of food products, to provide different selective and nutritional properties.  
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85-90 A NOVEL FUNCTIONAL PROBIOTIC PRODUCT CONTAINING PHENOLICS 
 AND  ANTHOCYANINS 
 Florinda Fratianni, Raffaele Coppola, Alfonso Sada, Jose Mendiola, Elena Ibañez and 
 Filomena Nazzaro 
 
ABSTRACT: The possibility of using fruit juice as growth medium for a bacterial strain was 
evaluated in order to produce a functional probiotic product. Lactobacillus acidophilus was 
capable of growing in a mixture of grape and berry juice, as demonstrated by the microbial 
count (5.41 x 108 colony-forming units/g) obtained after 24 h of fermentation. The microbial 
pellet was recovered by centrifugation, washed and freeze-dried. After freeze drying, the 
product was analyzed in terms of microbial amount and biochemical quality, and exhibited a 
high number of microorganisms (1.2 x 106 viable colony forming units/g), an extraordinary 
level of polyphenols and anthocyanins (total anthocyanins: 15.86 mg/g; malvidin 3-glycoside: 
10.8 mg/g; cyanidin-3-glycoside: 4 mg/g; total polyphenols: 312 mmol GAE/g of dried 
product; ferulic acid: 1 mg/g; gallic acid: 1.21 mg/; rutin: 6.45 mg/g; quercetin: 1.12 mg/g; 
epicatechin: 4.07 mg/g) as well as strong antioxidant activity (DPPH inhibition 86.6%). This 
formulation can be used for nutritional and health supplementation, thus increasing its value 
added. 
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91-96 THE USE OF PROBIOTIC STRAINS IN THE PRODUCTION OF A DONKEY 
 MILK-BASED FUNCTIONAL BEVERAGE 
 Filomena Nazzaro, Florinda Fratianni, Pierangelo Orlando, and Raffaele Coppola 
 
ABSTRACT: The capability of different probiotic strains of Lactobacillus spp. (L. 
acidophilus, L.bulgaricus, L. paraplantarum, L. plantarum, L. pentosus and L. rhamnosus) to 
ferment donkey milk was examined in order to investigate the possibility of formulating a 
probiotic milk beverage. Donkey milk was inoculated with different strains of Lactobacillus 
for 48 h. Microbial growth and fermentative aptitude was monitored as well as the microbial 
capability to produce short chain organic acids (SCOAs). All the strains were capable to grow 
in donkey milk, as demonstrated by the high microbial count (> 9 log colony forming units/ml) 
and low pH values. Chromatographic analysis evidenced that the fermented milk exhibited 
SCOAs other than lactic acid, ranging from 1.41 mmol/L of succinic acid (in milk fermented 
by L. paraplantarum) to 22.96 mmol/L of acetic acid (in product fermented by L. acidophilus). 
Butyric acid was present in all products. The possibility of using donkey milk as a growth 
medium for several probiotic strains, thereby giving rise to the production of a probiotic 
beverage with healthy SCOAs, can lead the way to a vast number of potential uses for this 
milk. 
 
International Journal of Probiotics & Prebiotics 5(2): 97-102 
 
97-102  THE ISOLATION OF LACTOBACILLUS STRAINS FROM HUMAN GUT FOR 
 USE AS POTENTIAL PROBIOTICS 
 Bin Wang, Zhiming Wang, Ning Li, Yousheng Li, Qiurong Li and Jieshou Li 
ABSTRACT: Eleven Lactobacillus strains of human intestine origin were examined in vitro 
for their probiotic potential characteristics. The characteristics studied include acid and bile 
tolerance, adhesion and antimicrobial effect on common pathogens. Most of the strains were 
able to resist pH 2.5 for 4 h, but only a few strains were able to tolerate 0.3 % oxgall 
concentrations for 24 h. There was wide variation in ability of strains to adhere to enterocyte-
like Caco-2 cells. The highest level of adherence was observed with Lactobacillus plantarum 
L2 (595±125.76/100 Caco-2 cells). The inhibition ability of isolates tested against common 
pathogens revealed that Lactobacillus plantarum L2 and Lactobacillus plantarum L6 
produced maximum zone of inhibition against some indicator microorganisms, and also 
displayed the broadest inhibitory spectrum by inhibiting four indicator microorganisms. 
Therefore, Lactobacillus plantarum L2 was found, in vitro, to possess desirable probiotic 
properties. 
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103-110  IN VITRO PROBIOTIC POTENTIAL OF LACTOBACILLI ISOLATED FROM 
 INDIGENOUS FERMENTED MILK PRODUCTS 
 Ravinder Nagpal, Ashwani Kumar and Sanu Arora 
 
ABSTRACT: In present study, Lactobacilli were isolated and characterized from various milk 
products, where out of 25 isolates, 5 lactobacilli strains were screened for probiotic properties 
viz. tolerance to low pH, high bile salt concentration, cholesterol assimilation, cell aggregation 
and heat tolerance etc. All the 5 isolates showed comparable cell-surface hydrophobicity, and 
inhibitory activity against B. cereus, E. coli, S. aureus, and Salmonella spp. However, the 
values for L. plantarum M5 were significantly higher than that of other isolates. Besides these 
attributes, it could also withstand pH 2.5, and 50°C up to 20 min. The results of storage studies 
showed that storage at -20°C and 5-7°C had no effect on viable count, and it had good viability 
after 6 weeks of storage. The results suggest that L. plantarum M5 and L. helveticus L3 could 
be exploited for potential probiotic foods for better nutrition and health.  
 
